Toxic shock syndrome surveillance in UK children

被引:42
作者
Adalat, S. [1 ]
Dawson, T. [2 ]
Hackett, S. J. [3 ]
Clark, J. E. [4 ]
机构
[1] Evelina Childrens Hosp, London, England
[2] Alexandra Hosp, Dept Paediat, Redditch, Worcs, England
[3] Birmingham Heartlands Hosp, Dept Paediat, Birmingham B9 5ST, W Midlands, England
[4] Great North Childrens Hosp, Newcastle Upon Tyne, Tyne & Wear, England
关键词
A STREPTOCOCCAL INFECTIONS; INTRAVENOUS IMMUNOGLOBULIN; UNITED-STATES; THERAPY; DISEASE; EPIDEMIOLOGY;
D O I
10.1136/archdischild-2013-304741
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Toxic shock syndrome (TSS) is an acute toxin-mediated illness caused by toxin-producing strains of Staphylococcus aureus and Streptococcus pyogenes. There is no recent data regarding incidence, management and mortality of TSS in UK children. Methods Consultants from paediatric and burns units in the UK and Ireland, reported cases of TSS seen between November 2008 and December 2009, via the British Paediatric Surveillance Unit. Respondents were sent questionnaires requesting detailed information about TSS cases. Established criteria were used to divide cases into staphylococcal or streptococcal TSS. Results Forty-nine cases were identified overall; 29 cases of streptococcal TSS (18 confirmed and 11 probable) and 20 cases of staphylococcal TSS (15 confirmed and 5 probable). The incidence of TSS children in the UK & the Republic of Ireland was calculated to be 0.38 per 100 000 children. Children with staphylococcal TSS were older than those with streptococcal TSS (9.5 vs 3.8 years; p<0.003). Paediatric intensive care facilities were used for 78% of cases (invasive ventilatory support 69%; inotropic support 67%; haemofiltration 12%). Agents with antitoxin effects were underused; clindamycin 67%, intravenous immunoglobulin (IVIG) 20%, fresh frozen plasma 40%. There were eight deaths, all in the streptococcal group (28% of streptococcal cases)-none were given IVIG. Conclusions Streptococcal TSS was as frequent as staphylococcal TSS, contrasting with previous literature. Children with streptococcal TSS had a higher mortality than those with staphylococcal TSS (28% vs 0%; p<0.05). Recommended immunomodulatory agents (IVIG and clindamycin) were underused. This study highlights the need for a guideline to improve management of TSS in children.
引用
收藏
页码:1078 / 1082
页数:5
相关论文
共 35 条
  • [1] [Anonymous], 1997, MMWR Recomm Rep, V46, P1
  • [2] [Anonymous], MMWR MORB MORTAL WKL
  • [3] BONVENTRE PF, 1989, REV INFECT DIS, V11, pS90
  • [4] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION
    BREIMAN, RF
    DAVIS, JP
    FACKLAM, RR
    GRAY, BM
    HOGE, CW
    KAPLAN, EL
    MORTIMER, EA
    SCHLIEVERT, PM
    SCHWARTZ, B
    STEVENS, DL
    TODD, JK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03): : 390 - 391
  • [5] Bacterial toxicosis/toxic shock syndrome as a contributor to morbidity in children with burn injuries
    Brown, AP
    Khan, K
    Sinclair, S
    [J]. BURNS, 2003, 29 (07) : 733 - 738
  • [6] TOXIC SHOCK SYNDROME
    BUCHDAHL, R
    LEVIN, M
    WILKINS, B
    GOULD, J
    JAFFE, P
    MATTHEW, DJ
    DILLON, MJ
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1985, 60 (06) : 563 - 567
  • [7] Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: Case report and review
    Cawley, MJ
    Briggs, M
    Haith, LR
    Reilly, KJ
    Guilday, RE
    Braxton, GR
    Patton, ML
    [J]. PHARMACOTHERAPY, 1999, 19 (09): : 1094 - 1098
  • [8] Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P201
  • [9] Toxic shock syndrome in children: Epidemiology, pathogenesis, and management
    Chuang Y.-Y.
    Huang Y.-C.
    Lin T.-Y.
    [J]. Pediatric Drugs, 2005, 7 (1) : 11 - 24
  • [10] Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:: A European randomized, double-blind, placebo-controlled trial
    Darenberg, J
    Ihendyane, N
    Sjölin, J
    Aufwerber, E
    Haidl, S
    Follin, P
    Andersson, J
    Norrby-Teglund, A
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 333 - 340